Hiden Analytical Launches the ECL Series – A New Toolkit for Electrochemical Discovery
October 13, 2025
Hiden Analytical is proud to announce the launch of the ECL Series — a new range of versatile electrochemical accessories for the HPR-40 DEMS, making a turnkey system for the real-time analysis of gases and volatile species in electrochemical research, empowering researchers with new levels of flexibility and precision. A New Era of Electrochemical Analysis Each [...]
October 12, 2025
Shenzhen, CHINA – MGI Tech Co., Ltd. (“MGI”), a company dedicated to developing core tools and technologies that drive innovation in life sciences, today announced a milestone step toward globalizing its proprietary CoolMPSTM technology. The Company has signed an exclusive licensing agreement* through its US subsidiaries – MGI US LLC and Complete Genomics Inc. – with Swiss [...]
CIQTEK FESEM SEM4000Pro Installed at SYNERGIE4 Showroom — A New Step in Europe
October 10, 2025
CIQTEK has taken another important step forward in Europe with the installation of the SEM4000Pro Field Emission Scanning Electron Microscope (FE-SEM) at the SYNERGIE4 demonstration showroom in France. The new setup allows researchers and industrial users in Europe to experience high-resolution imaging, analytical performance, and ease of operation offered by the CIQTEK SEM4000Pro. The system provides outstanding image quality for fine microstructural observation [...]
MGI Tech and Genesis Healthcare Establish Collaboration to Advance Precision Health in Japan
October 10, 2025
TOKYO, JAPAN – MGI Tech Co., Ltd. (or its affiliates, together referred to as MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, and Genesis Healthcare Co.(“Genesis Healthcare”), a leading Japan-based genetic testing and research company, have recently the signed a Memorandum of Understanding (MoU) to establish a [...]
October 9, 2025
Hamburg -- Eppendorf is proud to announce the launch of its Deepwell Plates BioBased, made from min. 95 % second-generation feedstock (according to mass-balance-approach*). This innovative product represents a significant step forward in sustainable laboratory practices, aligning with Eppendorf's commitment to environmental stewardship and scientific advancement. The new Deepwell Plates BioBased are designed to meet [...]
October 9, 2025
Lausanne, Switzerland and Frederick, MD – Alithea Genomics, a leader in next-generation transcriptomic solutions, today announced the commercial launch of MERCURIUS™ Spheroid DRUG-seq, a novel, extraction-free RNA sequencing library preparation kit built for 3D spheroid models. This advancement extends Alithea’s MERCURIUS DRUG-seq technology into physiologically relevant 3D systems, bringing simplicity, sensitivity, and throughput to drug [...]
October 9, 2025
Grants Bio-Techne expanded commercial rights to develop a portfolio of genetics products beyond the recently launched AmplideX® Nanopore Carrier Plus Kit Establishes a framework to define and propose future portfolios Extends collaboration through 2032, reinforcing Bio-Techne's diagnostics growth strategy and strengthening relationship with Oxford Nanopore Technologies MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of [...]
October 9, 2025
Physician-scientist with experience spanning biomarker development and regulatory submissions joins to expand Tapestri’s reach to guide therapeutic insights SOUTH SAN FRANCISCO, Calif. -- Mission Bio, a leader in single-cell multi-omics for precision medicine, today announced the appointment of Zivjena Vucetic, M.D., Ph.D., as Chief Medical Officer. A physician-scientist with more than 15 years of experience [...]
Parse Biosciences Invalidates Scale Biosciences (now 10x Genomics) Patent
October 9, 2025
SEATTLE -- Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that the District Court for the District of Delaware has granted Parse’s Motion for Summary Judgment of Invalidity for Scale Biosciences’ 11,634,752 patent. The Court concluded that the claims of the ‘752 patent were invalid for lack of [...]
October 9, 2025
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced the launch of the NULISAqpcr™ BD-pTau217 Assay— a transformative leap in blood-based quantification of brain-derived phosphorylated tau 217 (pTau217)—a pivotal biomarker in Alzheimer’s disease research and other tauopathies. This first-of-its-kind assay is the only brain-derived single-plex solution available, setting a [...]

